Frequently asked questions
There is a rise in the use of enteral tube feeding formulas during the Covid-19 pandemic, along with the prevalence of several chronic illnesses and eating disorders. The adoption of enteral tube feeding is anticipated to rise over the forecast period as it plays a significant part in healing and rehabilitation.
North America accounted for the most heightened share in the global enteral tube feeding formulas market.
The increasing rate of preterm births, soaring healthcare costs, an aging population, and a growing preference for home care are the main factors propelling the global market for enteral tube feeding formulas.
The oncology segment had a major share in the global market in 2021.
The standard formulas segment had a major share in the global market.